CONMED shares are trading lower after the company reported Q1 financial results. Needham, Piper Sandler and Wells Fargo lowered their respective price targets on the stock.
Portfolio Pulse from Benzinga Newsdesk
CONMED's stock price declined following the announcement of its Q1 financial results. Subsequently, Needham, Piper Sandler, and Wells Fargo reduced their price targets for CONMED.
April 25, 2024 | 3:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CONMED's shares fell after reporting Q1 earnings, leading to lowered price targets by Needham, Piper Sandler, and Wells Fargo.
The decline in CONMED's stock price is a direct result of its Q1 financial performance not meeting expectations, which was further exacerbated by lowered price targets from major financial institutions. This indicates a bearish outlook in the short term as market sentiment adjusts to the new evaluations.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100